{
    "paper_id": "PMC7149965",
    "metadata": {
        "title": "Calls to the medical unit",
        "authors": [
            {
                "first": "Elizabeth",
                "middle": [],
                "last": "Thomas",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Beverley",
                "middle": [],
                "last": "Harden",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Jane",
                "middle": [],
                "last": "Cross",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Mary-Ann",
                "middle": [],
                "last": "Broad",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Matthew",
                "middle": [],
                "last": "Quint",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Paul",
                "middle": [],
                "last": "Ritson",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Sandy",
                "middle": [],
                "last": "Thomas",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "COPD exacerbations may be idiopathic or caused by bacterial or viral infection. Hypoxaemia will be the primary reason for the call out and the aim of physiotherapy is to establish the cause of hypoxaemia and treat as appropriate.",
            "cite_spans": [],
            "section": "COPD",
            "ref_spans": []
        },
        {
            "text": "Major causes of hypoxaemia in COPD exacerbation include:\u2022Bronchospasm\u2022Sputum retention\u2022Consolidation.\n",
            "cite_spans": [],
            "section": "COPD",
            "ref_spans": []
        },
        {
            "text": "Others common causes include:\u2022Cardiac event\u2022Pneumothorax\u2022Pulmonary embolus.\n",
            "cite_spans": [],
            "section": "COPD",
            "ref_spans": []
        },
        {
            "text": "Oxygen is a drug and should be prescribed. Prescription should include percentage, flow rate, delivery device and whether oxygen delivery is intermittent or continuous. Any changes to oxygen therapy should be discussed with medical staff. Prescription may be flexible, for example \u2018maintain sats between 88% and 92%\u2019, in which case the FiO2 can be changed as necessary until the desired saturation is reached.",
            "cite_spans": [],
            "section": "CONTROLLED OXYGEN THERAPY AND COPD",
            "ref_spans": []
        },
        {
            "text": "NB: Liaise with medical staff to establish target SpO2 levels for each individual patient. They may be as low as 80\u201385% in chronically hypoxic patients.",
            "cite_spans": [],
            "section": "CONTROLLED OXYGEN THERAPY AND COPD",
            "ref_spans": []
        },
        {
            "text": "The role of the physiotherapist in relation to oxygen therapy includes:\u2022Assessment of oxygenation prior to, during and following treatment\u2022Ensuring the patient is receiving oxygen as prescribed\u2022\nInforming medical staff of increasing oxygen requirements\u2022Humidification of FiO2 >30% (or lower if secretions are tenacious).\n",
            "cite_spans": [],
            "section": "CONTROLLED OXYGEN THERAPY AND COPD",
            "ref_spans": []
        },
        {
            "text": "Some patients with COPD are classified as oxygen sensitive and have a chronically raised PaCO2. They rely on a low PaO2 to stimulate breathing, rather than an altered pH. This is called hypoxic drive. If too much oxygen is given, their stimulus to breathe (low PaO2) is removed and the patient stops breathing, resulting in type II respiratory failure, sometimes called oxygen-induced respiratory acidosis.",
            "cite_spans": [],
            "section": "CONTROLLED OXYGEN THERAPY AND COPD",
            "ref_spans": []
        },
        {
            "text": "It is vital that all COPD patients receive controlled oxygen therapy until it is established whether they are oxygen sensitive (through arterial blood gas analysis).",
            "cite_spans": [],
            "section": "CONTROLLED OXYGEN THERAPY AND COPD",
            "ref_spans": []
        },
        {
            "text": "(Refer to Chapter 9.)\u2022Only consider NIV following optimal medical management and controlled O2 therapy.\u2022COPD patients are at risk of pneumothorax with positive pressure ventilation.\u2022Use controlled O2 therapy when removing from NIV.\n",
            "cite_spans": [],
            "section": "MANAGEMENT OF THE COPD PATIENT WITH RESPIRATORY ACIDOSIS REQUIRING NIV (#!start#BRITISH THORACIC SOCIETY STANDARDS OF CARE COMMITTEE 2002)#!sep#bib2#!sep#bibr#!end#",
            "ref_spans": []
        },
        {
            "text": "Physiotherapy can play an important role in establishing the cause of frequent admissions in some patients and in helping to prevent such admissions (Table 12.1\n).",
            "cite_spans": [],
            "section": "CAUSES OF READMISSION IN COPD",
            "ref_spans": [
                {
                    "start": 150,
                    "end": 160,
                    "mention": "Table 12.1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "It is important to establish the ceiling of treatment agreed by the patient, their family and their medical team. IPPV may be deemed futile, and the fully informed patient may decide that NIV is not in their best interest; treatment may consist solely of medications and physiotherapy.",
            "cite_spans": [],
            "section": "CARE OF THE PATIENT WITH END-STAGE COPD",
            "ref_spans": []
        },
        {
            "text": "Assess the patient and formulate your plan and goals in line with what the patient wishes to achieve. There may be some disparity between what you perceive as optimal treatment and what the patient consents to. Some patients may wish to limit treatment to symptom control while others may feel that any intervention will worsen shortness of breath, outweighing any benefits gained, and thus decline what physiotherapy has to offer. These patients, who have had years of coping with unpleasant and disabling symptoms and have often had multiple inpatient admissions, are able to make truly informed choices.",
            "cite_spans": [],
            "section": "CARE OF THE PATIENT WITH END-STAGE COPD",
            "ref_spans": []
        },
        {
            "text": "Patients with end-stage COPD, together with their families and carers, should have access to the full range of services offered by the multidisciplinary palliative care teams, including admission to hospices. Opioids, benzodiazepines, tricyclic antidepressants and oxygen therapy may be used for the palliation of breathlessness in patients unresponsive to other medical treatments. In the terminal stages of the disease, antisecretory agents may be useful.",
            "cite_spans": [],
            "section": "CARE OF THE PATIENT WITH END-STAGE COPD",
            "ref_spans": []
        },
        {
            "text": "Optimal medical management is essential during acute exacerbation of asthma and may include magnesium infusion, inhaled or nebulized bronchodilators (beta-2 agonists and antimuscarinics), inhaled, nebulized, oral or intravenous corticosteroids, and theophyllines. Antibiotics will be used if there is evidence of infection (\u2191white cell count, neutrophils and CRP, \u00b1 pyrexia) (Table 12.2\n).",
            "cite_spans": [],
            "section": "ACUTE ASTHMA",
            "ref_spans": [
                {
                    "start": 376,
                    "end": 386,
                    "mention": "Table 12.2",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "Pancreatitis can be acute (one-off occurrence), chronic where it persists even after the cause has been removed, or hereditary. Causes include gallstones, excessive alcohol consumption, hypertriglyceridaemia, viral infection, trauma, vasculitis or pregnancy.",
            "cite_spans": [],
            "section": "PANCREATITIS",
            "ref_spans": []
        },
        {
            "text": "The aim of physiotherapy is to identify and treat the cause of hypoxaemia (Table 12.3\n).",
            "cite_spans": [],
            "section": "PANCREATITIS",
            "ref_spans": [
                {
                    "start": 75,
                    "end": 85,
                    "mention": "Table 12.3",
                    "ref_id": "TABREF3"
                }
            ]
        },
        {
            "text": "Renal failure is characterized by raised urea and creatinine levels. Electrolytes may also become deranged (Tables 12.4,\n12.5\nand 12.6\n).",
            "cite_spans": [],
            "section": "TREATMENT OF THE RENAL PATIENT",
            "ref_spans": [
                {
                    "start": 108,
                    "end": 120,
                    "mention": "Tables 12.4,",
                    "ref_id": "TABREF4"
                },
                {
                    "start": 121,
                    "end": 125,
                    "mention": "12.5",
                    "ref_id": "TABREF5"
                },
                {
                    "start": 130,
                    "end": 134,
                    "mention": "12.6",
                    "ref_id": "TABREF6"
                }
            ]
        },
        {
            "text": "Oesophageal varices are extremely dilated submucosal veins in the oesophagus. They are a consequence of portal hypertension as seen in liver cirrhosis. They are very likely to bleed and are diagnosed via endoscopy (Table 12.7\n).",
            "cite_spans": [],
            "section": "OESOPHAGEAL VARICES",
            "ref_spans": [
                {
                    "start": 215,
                    "end": 225,
                    "mention": "Table 12.7",
                    "ref_id": "TABREF7"
                }
            ]
        },
        {
            "text": "Interstitial lung disease (ILD) refers to a group of lung diseases characterized by inflammation which often leads to pulmonary fibrosis. Fibrosis destroys the alveoli, interstitium and capillary network of the affected areas of lung resulting in a restrictive disorder (Table 12.8\n).",
            "cite_spans": [],
            "section": "INTERSTITIAL LUNG DISEASE",
            "ref_spans": [
                {
                    "start": 271,
                    "end": 281,
                    "mention": "Table 12.8",
                    "ref_id": "TABREF8"
                }
            ]
        },
        {
            "text": "Pneumonia results from an inflammation of the alveolar space, usually due to invasion by bacteria, viruses or fungi, or as a result of chemical or physical injury. In bacterial and fungal infection, alveoli fill with protein-rich fluid and debris from white blood cells. Sputum production also increases (Table 12.9\n).",
            "cite_spans": [],
            "section": "PNEUMONIA",
            "ref_spans": [
                {
                    "start": 305,
                    "end": 315,
                    "mention": "Table 12.9",
                    "ref_id": "TABREF9"
                }
            ]
        },
        {
            "text": "Interstitial pneumonia is characterized by patchy or diffuse inflammation of the interstitium (the area between the alveoli). The alveoli do not contain significant exudate.",
            "cite_spans": [],
            "section": "PNEUMONIA",
            "ref_spans": []
        },
        {
            "text": "Adult cystic fibrosis (CF) patients will have their own independent airway clearance regime. It may comprise of PD \u00b1 self-percussion and ACBT, PEP mask, Flutter device or the Acapella. You do not need to be an expert in all these techniques, but during infective exacerbation you need to assess the effectiveness of the normal regime, and assist with sputum clearance if necessary. Patients may benefit from PD and manual techniques performed by the physiotherapist. It is advisable to do one or two lung areas with each treatment. Treatment may need to be further modified in the patient with dyspnoea, e.g. modified PD, \u2191emphasis on breathing control (Association of Chartered Physiotherapists in Cystic Fibrosis 2002) (Table 12.10\n).",
            "cite_spans": [
                {
                    "start": 654,
                    "end": 720,
                    "mention": "Association of Chartered Physiotherapists in Cystic Fibrosis 2002)",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "CYSTIC FIBROSIS (ADULT)",
            "ref_spans": [
                {
                    "start": 722,
                    "end": 733,
                    "mention": "Table 12.10",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "Bronchiectasis is the abnormal dilatation of bronchi caused by destruction of muscular and elastic components of the bronchial walls. The airways lose their normal sputum clearance mechanisms. Causes include TB, pertussis, measles, aspiration of a foreign body or severe bacterial pneumonia (often in childhood). It is an obstructive lung disease and usually affects one or more lobes (commonly the lower lobes). Signs and symptoms include chronic purulent sputum production (sometimes several cupfuls a day), regular and often persistent respiratory tract infections, chronic cough, disturbed sleep, fatigue and finger clubbing. Bronchiectatic patients, like CF patients, usually have their own airway clearance regime. It may comprise of PD \u00b1 self-percussion and ACBT, PEP mask, Flutter device or the Acapella (see CF section above). In acute infective exacerbation they may require assistance to achieve effective sputum clearance. Common issues include type I respiratory failure, haemoptysis and infection control (see Table 12.10). In the later stages of the disease, patients may admit with type II respiratory failure requiring NIV or IPPV (see Chapter 9).",
            "cite_spans": [],
            "section": "BRONCHIECTASIS",
            "ref_spans": [
                {
                    "start": 1024,
                    "end": 1035,
                    "mention": "Table 12.10",
                    "ref_id": "TABREF1"
                }
            ]
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 12.1: Common causes of readmission in the COPD patient\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 12.10: Common issues in the treatment of adult CF patients\n",
            "type": "table"
        },
        "TABREF2": {
            "text": "Table 12.2: Common issues in the treatment of patients with acute asthma\n",
            "type": "table"
        },
        "TABREF3": {
            "text": "Table 12.3: Common issues in the management of the medical patient with pancreatitis\n",
            "type": "table"
        },
        "TABREF4": {
            "text": "Table 12.4: Common issues in the management of the patient with renal failure\n",
            "type": "table"
        },
        "TABREF5": {
            "text": "Table 12.5: Common issues when treating the patient with chronic or acute-on-chronic renal failure\n",
            "type": "table"
        },
        "TABREF6": {
            "text": "Table 12.6: Causes of cardiovascular instability in the patient with renal failure\n",
            "type": "table"
        },
        "TABREF7": {
            "text": "Table 12.7: Common issues when treating patients with oesophageal varices\n",
            "type": "table"
        },
        "TABREF8": {
            "text": "Table 12.8: Common issues when treating patients with pulmonary fibrosis\n",
            "type": "table"
        },
        "TABREF9": {
            "text": "Table 12.9: Management of patients with pneumonia\n",
            "type": "table"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Clinical guidelines for the physiotherapy management of cystic fibrosis",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Association of Chartered Physiotherapists in Cystic Fibrosis",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Non-invasive ventilation in acute respiratory failure",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "British Thoracic Society Standards of Care Committee",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Thorax",
            "volume": "57",
            "issn": "",
            "pages": "192-211",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "National Institute for Clinical Excellence",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}